Keywords: genzyme, 4th-qtr, revenue, jumps, biotechnology, major, fourth-quarter
Genzyme's 4th-qtr 2007 revenue jumps 21%
Article | 25 February 2008
US biotechnology major Genzyme's fourth-quarter 2007 revenue increased 21% year-on-year to $1.04 billion, as generally-accepted accounting principles net income increased to $78.9 million, or $0.29 ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Italy's pharma market slump set to continue, warns GlobalData
